Compound Detail
CHEMBL6068431
BENZGALANTAMINE GLUCONATE 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
COc1ccc2c3c1O[C@H]1C[C@@H](OC(=O)c4ccccc4)C=C[C@@]31CCN(C)C2.O=C(O)C(O)C(O)C(O)C(O)CO
Basic Information
| ChEMBL ID | CHEMBL6068431 |
| Name | BENZGALANTAMINE GLUCONATE |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | YOMFDYFCNHSIAU-VXYIJGMPSA-N |
| Parent Compound | CHEMBL5095056 |
| Active Moiety | CHEMBL5095056 |
0
Targets
0
Activities
0
Assay Types
0
PK Parameters
0
Publications
6
Known Names
3
Indications
1
Mechanisms
Molecular Properties
391.5
MW (Da)
3.72
ALogP
5
HBA
0
HBD
48.0
PSA (Ų)
0.59
QED
0
Ro5 Violations
3
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2024 |
| Availability | Prescription |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Acetylcholinesterase inhibitor | INHIBITOR | Acetylcholinesterase | ✓ | ✓ |
Indications
Dementia Alzheimer Disease Cognitive Dysfunction
Data from ChEMBL 36 via Core Engine